Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
385M
-
Number of holders
-
158
-
Total 13F shares, excl. options
-
174M
-
Shares change
-
+13.4M
-
Total reported value, excl. options
-
$3.41B
-
Value change
-
+$268M
-
Put/Call ratio
-
0.34
-
Number of buys
-
102
-
Number of sells
-
-48
-
Price
-
$19.56
Significant Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q4 2019
187 filings reported holding MRNA - Moderna, Inc. - COMMON STOCK as of Q4 2019.
Moderna, Inc. - COMMON STOCK (MRNA) has 158 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 174M shares
of 385M outstanding shares and own 45.3% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (50.9M shares), VANGUARD GROUP INC (17.3M shares), FMR LLC (16M shares), BlackRock Inc. (11.7M shares), Theleme Partners LLP (6.44M shares), STATE STREET CORP (5.41M shares), Bellevue Group AG (4.94M shares), MORGAN STANLEY (4.81M shares), Artal Group S.A. (4.61M shares), and Ropes Wealth Advisors LLC (4.13M shares).
This table shows the top 158 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.